
Heparin-induced thrombocytopenia (HIT) is a potentially life-threatening complication that occurs in about 1% to 5% of patients who receive heparin.1 Patients with HIT are at risk for the development of new thrombosis, including pulmonary embolism (PE). The mortality rate among patients with HIT and thrombosis is about 20% to 30%.2-5









































































































































































































































































































